Subclinical Atherosclerosis in Patients with Relapsing-remitting Multiple Sclerosis

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2021 Apr 27

PMID 33903956

Citations 2

Authors

Tomaz Omerzu

Jozef Magdic

Radovan Hojs

Uros Potocnik

Mario Gorenjak

Tanja Hojs Fabjan

Affiliations

Soon will be listed here.

Abstract

Background: Multiple sclerosis is an inflammatory disorder of the central nervous system. Inflammation may create high susceptibility to subclinical atherosclerosis. The purpose of this study was to compare subclinical atherosclerosis and the role of inflammatory cytokines between the group of patients with relapsing-remitting multiple sclerosis (RRMS) and healthy controls matched for age and sex.

Methods: The study group consisted of 112 non-diabetic and non-hypertensive RRMS patients treated with disease modifying drugs (DMD) and the control group was composed of 51 healthy subjects. The common carotid artery (CCA) intima media thickness (IMT) was investigated. Serum levels of risk factors for atherosclerosis and inflammatory cytokines were also determined.

Results: The mean CCA IMT (0.572 ± 0.131 mm vs. 0.571 ± 0.114 mm) did not differ (p > 0.05) between patients and controls. The RRMS patients' CCA IMT was significantly correlated with serum interleukin 6 (IL-6) (p = 0.027), high-sensitivity C-reactive protein (hs-CRP) (p = 0.027), cystatin C (p < 0.0005), glucose (p = 0.031), cholesterol (p = 0.008), LDL (p = 0.021), erythrocyte sedimentation rate (p = 0.001) and triglyceride (p = 0.018) level. We fitted generalized linear models in order to assess the relationship between CCA IMT and IL‑6 with adjustment for sex and age. The obtained results showed that adjusted for age (p < 0.001) and sex (p = 0.048) IL‑6 serum levels statistically significantly (p = 0.009) predict CCA IMT only in the RRMS group.

Conclusion: The findings of the present study suggest that when treated with DMD RRMS might not be an independent risk factor for early atherosclerosis presenting with arterial wall thickening; however, the results suggest a significant association of IL‑6 serum levels with CCA IMT only in the RRMS group.

Citing Articles

Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.

Najmi E, Mirzaasgari Z, Motamed M, Aslani A PLoS One. 2024; 19(11):e0314031.

PMID: 39561151 PMC: 11575821. DOI: 10.1371/journal.pone.0314031.

Carotid intima-media thickness measurements in patients with multiple sclerosis.

Farzan M, Esmaeili S, Mirzaasgari Z, Mahmoudi Hamidabad N, Alavi S, Joghataei M Ann Med Surg (Lond). 2022; 75:103348.

PMID: 35242318 PMC: 8866135. DOI: 10.1016/j.amsu.2022.103348.

References

Wingerchuk D, Weinshenker B . Disease modifying therapies for relapsing multiple sclerosis. BMJ. 2016; 354:i3518. DOI: 10.1136/bmj.i3518. View

Solaro C, Ponzio M, Moran E, Tanganelli P, Pizio R, Ribizzi G . The changing face of multiple sclerosis: Prevalence and incidence in an aging population. Mult Scler. 2015; 21(10):1244-50. DOI: 10.1177/1352458514561904. View

Lunde H, Assmus J, Myhr K, Bo L, Grytten N . Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. J Neurol Neurosurg Psychiatry. 2017; 88(8):621-625. PMC: 5537547. DOI: 10.1136/jnnp-2016-315238. View

Marrie R . Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol. 2017; 13(6):375-382. DOI: 10.1038/nrneurol.2017.33. View

Ranadive S, Yan H, Weikert M, Lane A, Linden M, Baynard T . Vascular dysfunction and physical activity in multiple sclerosis. Med Sci Sports Exerc. 2011; 44(2):238-43. DOI: 10.1249/MSS.0b013e31822d7997. View

Singh R, Mengi S, Xu Y, Arneja A, Dhalla N . Pathogenesis of atherosclerosis: A multifactorial process. Exp Clin Cardiol. 2009; 7(1):40-53. PMC: 2716189. View

Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S . Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study. Eur J Neurol. 2014; 21(11):1353-e88. DOI: 10.1111/ene.12518. View

Christiansen C . Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res. 2012; 34(8):746-53. DOI: 10.1179/1743132812Y.0000000051. View

Thormann A, Magyari M, Koch-Henriksen N, Laursen B, Soelberg Sorensen P . Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J Neurol. 2016; 263(12):2484-2493. DOI: 10.1007/s00415-016-8295-9. View

10.

Manouchehrinia A, Tench C, Maxted J, Bibani R, Britton J, Constantinescu C . Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain. 2013; 136(Pt 7):2298-304. PMC: 3692034. DOI: 10.1093/brain/awt139. View

11.

Marrie R, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D . Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010; 74(13):1041-7. PMC: 2848107. DOI: 10.1212/WNL.0b013e3181d6b125. View

12.

Gistera A, Hansson G . The immunology of atherosclerosis. Nat Rev Nephrol. 2017; 13(6):368-380. DOI: 10.1038/nrneph.2017.51. View

13.

Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2):292-302. PMC: 3084507. DOI: 10.1002/ana.22366. View

14.

Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

15.

Craven T, Ryu J, Espeland M, KAHL F, Mckinney W, Toole J . Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation. 1990; 82(4):1230-42. DOI: 10.1161/01.cir.82.4.1230. View

16.

Burdick L, PERITI M, Salvaggio A, Bertoli S, Mangiarotti R, Castagnone D . Relation between carotid artery atherosclerosis and time on dialysis. A non-invasive study in vivo. Clin Nephrol. 1994; 42(2):121-6. View

17.

London G, Guerin A, Marchais S, Pannier B, Safar M, Day M . Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996; 50(2):600-8. DOI: 10.1038/ki.1996.355. View

18.

Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T . High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995; 48(3):820-6. DOI: 10.1038/ki.1995.356. View

19.

Savage T, Clarke A, Giles M, Tomson C, Raine A . Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant. 1998; 13(8):2004-12. DOI: 10.1093/ndt/13.8.2004. View

20.

Pahor A, Hojs R, Gorenjak M, Rozman B . Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. Rheumatol Int. 2006; 27(2):119-23. DOI: 10.1007/s00296-006-0176-6. View